Commitment to Research
We’re trailblazers – driving innovation in both local and global GI care. With an unwavering commitment to research over the last 40 years, we’ve played a leading role in discovering new treatment options that dramatically improve quality of life for our patients and people around the world.
Dedicated to Discovering Solutions
Located in the heart of Cincinnati, our national research center conducts the most current GI studies on the market under the guidance of more than 20 Ohio GI physicians and expertly trained research staff.
We don’t lose hope and we don’t give up – if a patient’s condition isn’t responding to prescribed therapies, OGI staff provides seamless access to clinical research trials that offer cutting-edge solutions at no cost to participants.
Ohio GI has played a key role in pivotal trials leading to approval of new medications for these conditions
- Crohn’s disease
- Ulcerative Colitis
- Eosinophilic esophagitis
- Hepatitis C
A Long Tradition of Changing Lives
Research isn’t just our specialty – it’s our heritage. Ohio GI was built with a steadfast determination to bring groundbreaking therapeutic medications to patients suffering from GI and liver conditions. We have conducted over 1,000 GI and liver clinical trials over the past 3 decades. Blazing the trail for approval of new medications has dynamically impacted GI care and improved the lives of patients around the world.
We Don’t Lose Hope and We Don’t Give Up
At Ohio GI, we leave no stone unturned. We maintain more than 30 ongoing clinical trials at one time, harnessing our uniquely specialized experience to continuously study and improve treatments for GI conditions including:
- Ulcerative Colitis: Living with chronic inflammation in the large intestine is not only exhausting, it significantly impacts your quality of life. We’re determined to help you reach remission and get back to the activities you enjoy.
- Crohn’s disease: When chronic inflammation appears anywhere in the digestive tract, from the mouth all the way to the colon, the symptoms are often debilitating. Our research team works tirelessly to give you the relief you deserve.
- Non alcoholic liver disease (NASH): If excess fat builds up in the liver, the resulting inflammation can cause significant, life changing liver damage. Ohio GI is charging ahead to find new ways to prevent, detect and treat the disease – putting you back on a path to long-term health.
- GERD: Patients who live with persistent heartburn or pain while swallowing know how frustrating and limiting life with GERD can be. We are committed to discovering treatments that not only reduce symptoms but prevent future esophageal damage.
Patients in the tri-state area have the unique opportunity to gain access to world-renowned, state-of-the-art clinical trials right here at home. These pivotal studies connect you to new options for symptom relief and go on to improve the lives of people around the world.
You deserve to find relief. If you’re suffering from a GI or liver condition, explore our clinical research page for a complete list of trials that are currently open for enrollment.